Amarin (AMRN) Slumps as Role of Vascepa Downplayed

May 28, 2013 12:28 PM EDT Send to a Friend
Amarin (Nasdaq: AMRN) is lower Tuesday following news that its Vascepa ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login